Recruiting
Neoplasm
RecruitingStudy on the Safety and Effectiveness of ART0380 Alone or with Gemcitabine or Irinotecan for Patients with Advanced or Metastatic Solid Tumors
Registered drugNo placebo
Study on the Safety and Effectiveness of ART0380 Alone or with Gemcitabine or Irinotecan for Patients with Advanced or Metastatic Solid Tumors
Registered drugNo placebo
- Disease:Neoplasm
- Substances:ART0380 mesilateGemcitabine Hydrochloride+1
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:ART0380 mesilate

